0
Preliminary Program
Preliminary Program: Tuesday? May 20
Psychiatric News
Volume 38 Number 4 page 34-49

7 a.m.-8:30 a.m.

Industry-Supported Breakfast Symposia

IS28. Impairment of Structural Plasticity in Severe Mood Disorders: Causal or Collateral? (Part 2) Supported by Abbott Laboratories

    A. Reduced Hippocampal Volume in Adult Major Depression: The Role of Childhood Trauma Meena Vythilingham, M.D.

    B. Targeting Structural Plasticity for Optimal Treatment of Severe Mood Disorders Husseini K. Manji, M.D.

IS29. Impulsivity, Aggression, and Suicide: Versatility of Lithium and Mood Stabilizers (Part 2) Supported by Solvay Pharmaceuticals

    A. Lithium Treatment of Patients With Suicidal Affective Disorder: Risk Factors and Mediators Jan A. Fawcett, M.D.

    B. Effects of Lithium on Impulsivity, Aggression, and Suicide Frederick K. Goodwin, M.D.

IS30. Bipolar Disorder in Women: Special Considerations and Evolving Treatment (Part 2) Supported by GlaxoSmithKline

    A. Bipolar Illness and the Postpartum Period: Clinical Issues and Controversies Adele C. Viguera, M.D.

    B. Use of Antiepileptic Medications in Women Martha J. Morrell, M.D.

IS31. Managing the Spectrum of Psychotic Disorders (Part 2) Supported by Bristol-Myers Squibb Company

    A. Long-Term Effectiveness of Antipsychotic Therapies: Real-World Considerations Stephen R. Marder, M.D.

    B. Evolving Role of Novel Antipsychotics for the Management of Acute Mania Terence A. Ketter, M.D.

IS32. Treating Depression: What Matters? (Part 2) Supported by Eli Lilly and Company

    A. Bipolar Matters Lori L. Altshuler, M.D.

    B. Treatment Matters Andrew A. Nierenberg, M.D.

IS33. Evidence-Based Treatment of Psychiatric Disorders (Part 2) Supported by Wyeth Pharmaceuticals

    A. Evidence-Supportive Therapies for GAD and Social Anxiety Disorder Jack M. Gorman, M.D.

    B. Evidence-Based ECT and Transcranial Magnetic Stimulation Sarah H. Lisanby, M.D.

IS34. Managing Anxiety and Sleep: A New Era for Gamma-Aminobutyric Acid (Part 2) Supported by Cephalon Inc.

    A. Novel Gamma-aminobutyric acid Treatments in Neuropsychiatric Disorders Stephen M. Stahl, M.D.

    B. In Vivo Measurements of Gamma-aminobutyric Acid in Neuropsychiatric Disorders Linda Chang, M.D

7:30 a.m.-6 p.m.

Registration/Course Enrollment Open

8 a.m.-Noon

CME Courses 60-68

9 a.m.-10:30 a.m.

Clinical Case Conference 2. Curley L. Bonds, M.D., on Dyskinesias in a Somatically Preoccupied Patient After Treatment With Atypical Antipsychotics (Open to APA members only.)

Debate

2. Resolved: Racism Is a Mental Disorder Moderator: Geetha Jayaram, M.D., Affirmative: Alvin F. Poussaint, M.D., Negative: Robert T.M. Phillips, M.D.

Discussion Groups

    10. Lauren B. Marangell, M.D., on Practical Psychopharmacology for the Busy Clinician (Meet the Authors)

    11. Rodrigo A. Muñoz, M.D., on Protecting Clinical Autonomy

    12. Dilip V. Jeste, M.D., on Schizophrenia and Aging

    13. Chowallur D. Chacko, M.D., on An Introduction to Starting a Forensic Psychiatric Practice

Lectures

    L9. To Be Determined

    L10. Genes, Family Relationships, and DSM-VDavid Reiss, M.D., APA’s Adolf Meyer Award Lecture

Master Educator Clinical Consultation

    5. T. Byram Karasu, M.D., on Psychotherapeutic Diagnoses and Treatment Planning (Open to APA members only.)

Component Workshops

    CW10. Practical Tips on How to Be a Successful Author American Psychiatric Publishing Inc. Editorial Board Chairperson: Robert E. Hales, M.D.

    CW11. How to Provide Geriatric Psychiatry During Residency APA Committee on Access and Effectiveness of Psychiatric Services for the Elderly Chairperson: Colleen J. Northcott, M.D.

    CW12. Psychiatric Management of HIV, Hepatitis C, and Substance Abuse APA Committee on AIDS Chairperson: Milton L. Wainberg, M.D.

    CW13. IMGs: Challenges and Solutions APA Committee on International Medical Graduates Co-Chairpersons: Josie L. Olympia, M.D., Godehard Oepen, M.D.

    CW14. New APA Ethics Procedures: Implications for the Profession (Part 1) APA Ethics Appeal Board Co-Chairpersons: Richard D. Milone, M.D., Pedro Ruiz, M.D.

    CW15. Career Choices in Psychiatry: Exploring Fellowship Training APA Assembly Committee of Area Member-in-Training Representatives Chairperson: Caroline E. Fisher, M.D.

    CW16. It Doesn’t Happen to Us: Insider’s View of Trauma in Minority Communities APA/Center for Mental Health Services and APA/AstraZeneca Minority Fellows Chairperson: Napoleon B. Higgins Jr., M.D.

    CW17. Racism: Diagnostic and Treatment Considerations APA Committee of Black Psychiatrists Chairperson: Michelle O. Clark, M.D.

Issue Workshops

    IW35. Brief Psychodynamic Psychotherapy of Panic: A Learning-Strategy Approach Co-Chairpersons: Bryan K. Touchet, M.D., Kim A. Coon, L.P.C.

    IW36. Consent Evaluations: Assessing Capacity for Decision Making and for Voluntarism Chairperson: Laura W. Roberts, M.D.

    IW37. Artistic Use of the Creative Unconscious in the Therapeutic Alliance Co-Chairpersons: Ian E. Alger, M.D., Ferruccio A. di Cori, M.D.

    IW38. Psychiatry Training for Primary Care Physicians: What, How Much, and How? Chairperson: Hoyle Leigh, M.D.

    IW39. Dynamic Therapy With Self-Destructive Borderline Patients Co-Chairpersons: Eric M. Plakun, M.D., Edward R. Shapiro, M.D.

    IW40. The Development, Implementation, and Operation of Diverse Telepsychiatry Programs Chairperson: Norman E. Alessi, M.D.

    IW41. Challenging Behavior, Mental Illness, and Developmental Disabilities Co-Chairpersons: Earl L. Loschen, M.D., Robert J. Pary, M.D.

    IW42. Treatment of Schizophrenia: Antipsychotic Polypharmacy Versus Mono-therapy Chairperson: Andre Tapp, M.D.

    IW43. Relevant Data for the Practicing Psychiatrist: Comorbidities/Combined Treatment Chairperson: Daniel A. Deutschman, M.D.

    IW44. The Benzodiazepine Controversy Co-Chairpersons: Christopher K. Chung, M.D., Dean M. De Crisce, M.D.

    IW45. Surgeon General’s Report on Culture, Race, and Ethnicity: Clinical Implications Chairperson: Theresa M. Miskimen, M.D.

    IW46. The Psychiatric Care of Survivors of Torture Chairperson: Asher D. Aladjem, M.D.

    IW47. Development of the School-Based Adolescent Depression Awareness Program Co-Chairpersons: Karen L. Swartz, M.D., Todd S. Cox, M.D.

    IW48. Developments in Cognitive Therapy for Schizophrenia Chairperson: David G. Kingdon, M.D.

    IW49. Psychiatric Illness and the Workplace Chairperson: Steven E. Pflanz, M.D.

    IW50. Psychiatric Perspectives on the Execution Process: A Continuing Conundrum Chairperson: Howard J. Osofsky, M.D.

    IW51. From Neuropathology to Treatment: Emerging Treatment Strategies for Alzheimer’s Disease Chairperson: Jacobo E. Mintzer, M.D.

    IW52. The Emerging Role of Psychiatry in a Bioterrorism Response Chairperson: Anthony T. Ng, M.D.

    IW53. How to Launch a Successful Private Practice (Part 1) Co-Chairpersons: William E. Callahan Jr., M.D., Keith W. Young, M.D.

9 a.m.-11 a.m.

Research Advances in Medicine

9 a.m.-Noon

Continuous Clinical Case Conference 1. Richard L. Munich, M.D., and Efram Bleiberg, M.D., on Treatment of the VIP Patient: Two Patients, Two Therapists (Part 2) (Open to APA members only.)

9 a.m.-12:30 p.m.

Review of Psychiatry (Part 1): 2003 Psychiatry Update: Trauma and Disaster Responses and Management Co-Chairpersons: Robert J. Ursano, M.D., Ann E. Norwood, M.D.

9 a.m.-4 p.m.

CME Courses 69-74

10 a.m.-6 p.m.

Exhibits Open

Publishers’ Bookfair Open

APA Resource Center Open

11 a.m.-12:30 p.m.

Discussion Groups

    14. Raphael J. Leo, M.D., on An Update on Pain Management (Meet the Authors)

    15. Anita L.H. Clayton, M.D., on Clinical Implications of Sexual Dysfunction in Depression

    16. Steven S. Sharfstein, M.D., on Psychiatric Leadership in the Medical Marketplace

    17. Glen O. Gabbard, M.D., on Maintaining and Developing Family Relationships During Residency (For residents only)

Lectures

    L11. Title to Be Determined Christopher A. Ross, M.D., Frontiers of Science Lecture Series

    L12. The Search for Genes of Bipolar Disorder: From Classical Genetics to Novel Molecular Targets Julien Mendlewicz, M.D., International Psychiatrist Lecture Series

Master Educator Clinical Consultations

    6. Stephen M. Goldfinger, M.D., on Engaging the Disengaged: Connecting With Marginalized Patients (Open to APA members only.)

    7. Philip R. Muskin, M.D., on Rational or Rationalized Suicide? An Ethical/Clinical Dilemma (Open to APA members only.)

Medical Update 2. Louann Brizendine, M.D., on Menopause: What Psychiatrists Need to Know

Research Consultation 1. J. Raymond DePaulo Jr., M.D., on The Genetics of Bipolar Disorder and Other Psychiatric Phenotypes

Scientific and Clinical Report Sessions

Session 8. Mood and Anxiety Disorders in Children and Adolescents

    23. Management of Adolescent Mania Melissa P. DelBello, M.D.

    24. Exploratory Factor Analysis of BPD Criteria in Hospitalized Adolescents Daniel F. Becker, M.D.

    25. Gender Differences in Comorbidities in Child and Adolescent GAD Atilla Turgay, M.D.

Session 9. Depressive Disorders

    26. Continuation Cognitive-Behavioral Therapy Maintains Attributional Style Improvement in Depressed Patients Responding Acutely to Fluoxetine Timothy J. Petersen, Ph.D.

    27. The Potential Relationship Between Levels of Perceived Stress and Specific Subtypes of Major Depression Amy H. Farabaugh, Ph.D.

    28. Symptom Severity and Exclusion From Antidepressant Efficacy Trials Mark Zimmerman, M.D.

Session 10. Neuropsychiatry

    29. Dyslexia as a Potential Index of Neurocognitive Impairments in Patients With Schizophrenia Giuseppe Bersani

    30. Previous Head Injuries in Psychiatric Inpatients Edward Kim, M.D.

    31. Neurofeedback to Increase Remission Rates in Depression Leo I. Jacobs, M.D.

Session 11. Adult ADHD

    32. Efficacy and Safety of Atomoxetine in Adults With ADHD Thomas J. Spencer, M.D.

    33. Adderall XR Dosed Once Daily in Adult Patients With ADHD Richard H. Weisler, M.D.

    34. Alpha-1 Agonist Prazosin for ADHD: The Role of Norepinephrine in ADHD Pathology Fletcher B. Taylor III, M.D.

Session 12. Treatment Options in ADHD

    35. Placebo-Controlled Study of Once-Daily Atomoxetine in the School Setting Christopher J. Kratochvil, M.D.

    36. Modafinil Improves ADHD Symptoms in Children in a Randomized, Double-Blind, Placebo-Controlled Study Joseph Biederman, M.D.

    37. Safety and Efficacy of OROS MPH in Adolescents With ADHD Laurence L. Greenhill, M.D.

Session 13. Pharmacotherapy of Depression

    38. Onset and Maintenance of Antidepressant Efficacy for Duloxetine 60 mg QD Stephen K. Brannan, M.D.

    39. Depressive Subtypes and Response to Augmentation or Dose Increase Among Outpatients Resistant to Fluoxetine 20 mg a Day Roy H. Perlis, M.D.

    40. Treatment-Related Adverse Events in a 20 mg Open Trial of Fluoxetine: Predictors of Emergence and Impact on the Course of Treatment George I. Papakostas, M.D.

Session 14. Mood Disorders and Somatic Illness

    41. Cardiovascular Risk Factors Predict Treatment Outcome in MDD Dan V. Iosifescu, M.D.

    42. Prevalence and Characteristics of Patients With Depression and/or Chronic Pain Bruce A. Arnow, Ph.D.

    43. Effectiveness of Collaborative Care in a Depressed, Poor, Primary Care Sample Lawson R. Wulsin, M.D.

Session 15. Child and Adolescent Psychopharmacology

    44. Modafinil in Children With ADHD: A Randomized, Placebo-Controlled Study James M. Swanson, M.D.

    45. Quetiapine Use in Children and Adolescents: A Literature Review Brian J. McConville, M.D.

    46. Clinical Review of OROS MPH in Children, Adolescents, and Adults With ADHD Timothy E. Wilens, M.D.

Session 16. Predictors of Suicide

    47. Personality Traits as Predictors of Suicidality in Young Women Joel F. Paris, M.D.

    48. Suicidal Behavior in Violent and Nonviolent Psychiatric Patients Menahem I. Krakowski, M.D.

    49. Obstetric Complications and Suicide Risk in Adolescence and Young Adulthood Richard Neugebauer, Ph.D.

Session 17. Schizophrenia and Other Psychotic Disorders

    50. Elevated Maternal Cytokine Levels and Schizophrenia in Adult Offspring Alan S. Brown, M.D.

    51. Association Between Psychotic Symptoms and Seizures in a Community Sample Christine L. Baker, M.P.H.

    52. Biological Mechanisms in Schizophrenic Thought Disorder and Delusions Martin Harrow, Ph.D.

Session 18. Epidemiology

    53. Diagnoses in Behavioral Health Clinics: Impact on Perceived Burden of Mental Health Abigail L. Garvey-Wilson, M.D.

    54. The Treatment Gap in Mental Health Care Robert Kohn, M.D.

    55. Projecting National Survey Prevalences to Populations of Interest Stephen C. Messer, Ph.D.

Component Workshops

    CW18. Encountering the Spiritual in Psychiatric (Psychotherapy) Practice Northern California Psychiatric Society Chairperson: Kalpana I. Nathan, M.D.

    CW19. Sexual Harassment: Victims Face Confidentiality Issues in Psychiatric Care APA Committee on Women Co-Chairpersons: Rita R. Newman, M.D., Annette J. Hollander, M.D.

    CW20. Patient Safety in Psychiatry: Reducing Inpatient Suicide APA Committee on Quality Indicators Co-Chairpersons: Miles F. Shore, M.D., Alfred Herzog, M.D.

    CW21. New APA Ethics Procedures: Implications for the Profession (Part 2) APA Ethics Committee and APA Ethics Appeal Board Chairperson: Wade C. Myers, M.D.

    CW22. AIDSism, Ageism, Racism: Psychiatrist’s Role in the Geriatric AIDS Epidemic New York County District Branch’s AIDS Committee Co-Chairpersons: Kenneth B. Ashley, M.D., Mary Ann Cohen, M.D.

Issue Workshops

    IW54. Spiritual and Religious Assessment in Clinical Practice Co-Chairpersons: Francis G. Lu, M.D., Christina M. Puchalski, M.D.

    IW55. Career Development and Risk Management Co-Chairpersons: Joseph M. Schwartz, M.D., George A. Fouras, M.D.

    IW56. Therapeutic Issues in Self-Injurious Behavior Co-Chairpersons: Jose A. Yaryura-Tobias, M.D., Fugen Neziroglu, Ph.D.

    IW57. Technology Serves the Patient: Algorithms, Monitoring, and Decision Support Chairperson: Daniel A. Deutschman, M.D.

    IW58. Women in Academic Psychiatry: Opportunities, Obstacles, and Strategies Co-Chairpersons: Carolyn B. Robinowitz, M.D., Carol C. Nadelson, M.D.

    IW59. The Art of the Unconscious: Shakespeare, Poetry, Film, and Psychiatry Chairperson: Steven E. Pflanz, M.D.

    IW60. Asian Indians in Interfaith Marriages: Challenges, Conflicts, and Compromises Indo-American Psychiatric Association Chairperson: Jagannathan Srinivasaraghavan, M.D.

    IW61. The Role of the Soul: The Impact of Spiritual Belief Systems of Healing Chairperson: Walter R. Byrd Jr., M.D.

    IW62. Post-Genocide Psychological Trauma in Film: Under the Domin Tree Co-Chairpersons: Maurice Preter, M.D., and Harold J. Bursztajn, M.D.

    IW63. How to Launch a Successful Private Practice (Part 2) Co-Chairpersons: William E. Callahan Jr., M.D. and Keith W. Young, M.D.

Noon-1:30 p.m.

Forums

    4. Neurobiology of Parent-Child Relationships: Applications to Psychotherapy APA Committee on Psychotherapy by Psychiatrists Chairperson: Bernard D. Beitman, M.D. Co-Chairperson: Eva M. Szigethy, M.D.

    5. Terrorism and Psychosocial Preparedness Chairperson: Howard J. Osofsky, M.D.

    6. Prozac on the Couch Chairperson: Jonathan M. Metz, M.D.

    7. Intimate Partner Violence and Abuse: Identification and Intervention Within a Behavioral Health Study Chairperson: Penny K. Randall, M.D.

Noon-2 p.m.

New Research Poster Session 6

1 p.m.-5 p.m.

CME Courses 75-81

2 p.m.-3:30 p.m.

Lectures

    L13. Psychiatric Organizational Leadership: Reflections, Predictions, Proposals Carolyn B. Robinowitz, M.D., Distinguished Psychiatrist Lecture Series

    L14. The Healer’s Art: Undergraduate Education for Meaning and Commitment Rachel N. Remen, M.D.

    L15. Mental Illness, Human Rights, Science, and Culture: A Videotaped Documentation of Conditions in Mexican Psychiatric Hospitals Robert L. Okin, M.D., Frontiers of Science Lecture Series

2 p.m.-5 p.m.

Presidential Symposium

The Foundation of Medical Ethics/Informed Consent Chairperson: William T. Carpenter Jr., M.D. Co-Chairperson: Dilip V. Jeste, M.D.

Symposia

S29. Integrated Treatment: Psychopharmacology and Psychotherapy

    A. Integrated Treatment: From Adolescence to Young Adulthood Hans Steiner, M.D.

    B. Integrated Treatment of BPD Glen O. Gabbard, M.D.

    C. Integrated Treatment of Eating Disorders Kathryn J. Zerbe, M.D.

    D. Psychiatric and Medical Illness David Spiegel, M.D.

    E. Integrated Treatment of Juvenile Bipolar Disorder Kiki D. Chang, M.D.

S30. Recent Developments in Gay and Lesbian Mental Health: A Global Perspective APA Committee on Gay, Lesbian, and Bisexual Issues

    A. From Long Yong and Dui Shi to Tongzhi: Homosexuality in China Jin Wu, M.A.

    B. Look to Norway? Gay Issues and Mental Health Across the Atlantic Ocean Reidar Kjaer, M.D.

    C. Voices From the Past: Treatments of Homosexuality in the United Kingdom Since 1950 Michael B. King, M.D.

    D. Emergence of Lesbian and Gay Issues in International Psychiatry Gene A. Nakajima, M.D.

S31. New Research in Gay, Lesbian, and Bisexual Mental Health Morbidity

    A. Estimates of Mental Health Morbidity Among Lesbian, Gay, and Bisexual Adults Susan D. Cochran, Ph.D.

    B. Sexual Orientation and Health: New Findings From a Dutch General-Population Survey Theodorus G.M. Sandfort, Ph.D.

    C. Minority Stress and Mental Health in Lesbians, Gay Men, and Bisexuals Ilan H. Meyer, Ph.D.

    D. Depressive Distress in a Community Sample of Women: The Role of Sexual Orientation Alicia K. Matthews, Ph.D.

    E. Sexual Minority Status and Its Association With Suicidality and Depression Jay P. Paul, Ph.D.

S32. An Update on Parkinson’s Disease and Its Psychiatric Complications

    A. Parkinson’s Disease: Update on Treatment, Etiology, and Pathogenesis Margery Mark, M.D.

    B. Depression in Parkinson’s Disease Jeffrey L. Cummings, M.D.

    C. Psychosis in Parkinson’s Disease Laura Marsh, M.D.

    D. Cognitive Impairment, Dementia, and Parkinson’s Disease Constantine Lyketsos, M.D.

    E. Anxiety, Fatigue, and Sleep in Patients With Parkinson’s Disease Matthew A. Menza, M.D.

S33. Coping With Catastrophe

    A. Psychotherapy of the Dying Patient John W. Barnhill, M.D.

    B. Illness in the Training Psychiatrist Gregory C. Dillon, M.D.

    C. Treating Firefighers in the Aftermath of 9/11 Kevin V. Kelly, M.D.

S34. Strategies to Overcome Resistance

    A. Resistance and Psychodynamics R. Rao Gogineni, M.D.

    B. Overcoming Resistance: Techniques From Cognitive Therapy Donna M. Sudak, M.D.

    C. Resistance by Families and Children in Psychotherapy G. Pirooz Sholevar, M.D.

    D. Diagnostic and Treatment Algorithms for Refractory Depression Jay D. Amsterdam, M.D.

S35. Developing Culturally Competent Services for Minority Populations APA Assembly Committee of Representatives of Minority/Underrepresented Groups

    A. Psychiatric Care of Hispanic Americans: Problems and Solutions Pedro Ruiz, M.D.

    B. Developing Services for African Americans William B. Lawson, M.D.

    C. Developing Culturally Competent Mental Health Services for Asian Americans Evelyn Lee, Ph.D.

    D. New Approaches for Developing Mental Health Services for Native Americans R. Dale Walker, M.D.

S36. The Ethnicity Factor in Psychiatric Research: Identity and Methodology Issues American Society of Hispanic Psychiatry

    A. Cultural Variables and Controversies: The Identity Issue Renato D. Alarçon, M.D.

    B. Cultural Issues Among Hispanics: A Portrait of Heterogeneity Andres Heerlein, M.D.

    C. Methodological Issues in Ethnicity Research Javier I. Escobar, M.D.

    D. The Inclusion of Race and Ethnicity in Current Psychiatric Literature Roberto Lewis-Fernandez, M.D.

    E. Training Culturally Competent Researchers Miguel R. Jorge, M.D.

S37. What the General Psychiatrist Needs to Know About Addiction Psychiatry APA Council on Addiction Psychiatry and American Academy of Addiction Psychiatry

    A. Neuroscience of Addictions Bryon H. Adinoff, M.D.

    B. Treatment of Addictions Charles P. O’Brien, M.D.

    C. Dual Diagnosis Douglas M. Ziedonis, M.D.

    D. Consultation Psychiatrists: Frontline Observers of New Trends in Addiction Joel E. Dimsdale, M.D.

    E. Current Issues in Addiction Medicine: Club Drugs Alvaro Camacho, M.D.

S38. Early Trauma: Strategies for Intervention and Treatment

    A. The Early Trauma Treatment Network: Assessing and Treating Trauma in Young Children Alicia F. Lieberman, Ph.D.

    B. Treatment of PTSD in Infants and Young Children Theodore J. Gaensbauer, M.D.

    C. Prevention and Intervention for Young Children Exposed to Violence Joy D. Osofsky, Ph.D.

S39. Early Intervention in Psychosis: Where Science Meets Community Psychiatry American Association of Community Psychiatrists

    A. Early Detection and Management of Psychiatric Disorder in Young People in Melbourne, Australia Patrick D. McGorry, M.D.

    B. Intervention in the Schizophrenic Prodrome: The Prevention Through Risk Identification, Management, and Education Initiative Thomas H. McGlashan, M.D.

    C. Portland Identification and Early Referral: First-Year Outcomes in a Community-Wide Psychosis Prevention Program William R. McFarlane, M.D.

    D. A Comprehensive Approach to Early Intervention in Psychosis: The Prevention and Early Intervention Program for Psychosis Project (PEPP) Ashok K. Malla, M.D.

    E. The Tips Project: Clinical and Organizational Prerequisites for Early Intervention in Psychosis Jan O. Johannessen, M.D.

    F. Implementing Early Psychosis Intervention in the Public Mental Health System Robert M. Wolf, M.D.

S40. Dehydroepiandrosterone: Neuro-steroid Mechanisms, Epidemiology, and Applications in Psychiatry

    A. Dehydroepiandrosterones: Neurosteroid Modulator of Brain Excitability, Mood, Cognition, and Drug Maria Majewska

    B. Dehydroepiandrosterone Treatment of Alzheimer’s Disease and Major Depression Victor I. Reus, M.D.

    C. Dehydroepiandrosterone Effects on Mood in HIV and Depressed Patients Judith G. Rabkin, Ph.D.

S41. Science and Psychiatric Participation in Disaster Response

    A. Psychiatry and Somatic Medicine in Disaster Response: Carved Out Again? Michael J. Kaminsky, M.D.

    B. What You Need to Know to Get Yourself and Your Organization Ready to Respond to Disasters George Everly Jr., Ph.D.

    C. Current Science About Best Practices in Disaster Psychiatry and a Proposed Research Agenda Michael C. Heitt, Psy.D.

    D. Postdisaster Science of Therapeutic Healing Everett R. Siegel, M.D.

S42. Recovery From Schizophrenia: A Challenge for the 21st Century

    A. Operational Criteria and Factors Related to Recovery From Schizophrenia Robert P. Liberman, M.D.

    B. Recovery in First-Episode Schizophrenia Delbert G. Robinson, M.D.

    C. Schizophrenia and Capacity for Vocational Recovery Zlatka L. Russinova, Ph.D.

    D. The Process of Recovery From Schizophrenia LeRoy Spaniol, Ph.D.

    E. Multiple Dimensions of Recovery in Early Psychosis David Whitehorn, Ph.D.

S43. The Invisible Plague: Severe Mental Illness

    A. Evidence for the Existence of Schizophrenia Before 1750 and What That May Mean Nigel M. Bark, M.D.

    B. Management of the Mad in 17th-Century England: The Rise of Confinement Richard Neugebauer, Ph.D.

    C. Political Influence on Psychiatry: Malevolent or Benevolent? Nasser F. Loza, M.B.

    D. The Increasing Incidence of Psychoses From 1750 to the Present E. Fuller Torrey, M.D.

    E. Criminalization of Persons With Mental Illness in the 20th and 21st Centuries H. Richard Lamb, M.D.

S44. The Evil Standard: Milestones and Challenges

    A. Undefined Evil: The Legal, Psychiatric, and Societal Consequences of Avoidance Michael M. Welner, M.D.

    B. Researching the Depravity Standard: Reliability in Defining a Distinctive Crime James Seward, Ph.D.

    C. The Depravity Scale in Relation to the Histories of 430 Convicted Killers Michael H. Stone, M.D.

    D. The Civil Employment Depravity Scale: Preliminary Items and Research Michael M. Welner, M.D.

S45. Bereavement After Violent Death

    A. The Effects of Violent Death on Bereavement Beverley Raphael, M.D.

    B. Community-Based Interventions With Child and Adolescent Survivors of Homicide Victims Alison A. Salloum, M.S.W.

    C. Survivors of Violent Loss Program Stephen R. Shuchter, M.D.

    D. Terrorism Factors That Exacerbate the Experience of Victims Kathryn M. Turman

    E. The Long-Term Psychological Effects of the World Trade Center Disaster: Community Strategies for Support Vilma Torres, M.S.W.

S46. Diverse Approaches to Alzheimer’s Screening

    A. Mini-Cog Soo Borson, M.D.

    B. Memory Impairment Screen Herman Buschke, M.D.

    C. Brief Alzheimer’s Screen Marta S. Mendiondo, Ph.D.

    D. The Computer-Administered Neuropsychological Screening for Mild Cognitive Impairment: Self-Administered Screening for Mild Cognitive Impairment Jane B. Tornatore, Ph.D.

    E. Bowles-Langley Technology/Ashford Memory Test Online Version John W. Ashford Jr., M.D.

    F. Statistical Issues in Evaluating Alzheimer’s Screening Tests Helena C. Kraemer, Ph.D.

S47. Personal Identity and Bipolar Disorder

    A. Creating Narrative From Disjunction: The Clinical Picture Deborah Spitz, M.D.

    B. Bipolar Disorder and Parfitian Successive Selves Jennifer Radden, Ph.D.

    C. Narrative Selves, Relations of Trust, and Bipolar Disorder Nancy Potter, Ph.D.

    D. Values and the Nature of Bipolar Disorder Kenneth Fulford, D.Phil.

S48. The Spectrum of Sexual Violence: Clinical and Cultural Impact American Academy of Child and Adolescent Psychiatry

    A. Childhood Sexual Abuse and Later Adolescent Risk Behavior Larry K. Brown, M.D.

    B. Perspectives on Sexual Molestation of Boys by Roman Catholic Priests Lynn E. Ponton, M.D.

    C. Sexual Violence on the Internet Norman E. Alessi, M.D.

    D. Dating Violence and African-American Adolescent Females’ Sexual Health Ralph DiClemente, Ph.D.

    E. Adolescent Dating Violence: Screening Practices of Child and Adolescent Psychiatrists Kristie Puster, Ph.D.

S49. Advances in Understanding and Treating Chronic Depression

    A. Classification and Natural History of Chronic Depression Daniel N. Klein, Ph.D.

    B. Cognitive-Behavioral Analysis System of Psychotherapy Bruce A. Arnow, Ph.D.

    C. Treating Chronic Depression: Psychosocial Outcomes James H. Kocsis, M.D.

    D. Continuation, Maintenance, and Crossover Results of Clinical Trials Alan J. Gelenberg, M.D.

    E. Interpersonal Psychotherapy for Chronic Depression John C. Markowitz, M.D.

S50. Boundary Crossings: Creative Therapy or Slippery Slopes?

    A. Boundary Violations Versus Boundary Crossings Gail E. Robinson, M.D.

    B. Creative Moments and Challenging Events in Therapy: Bending Rules to Help Gary R. Schoener, Psy.D.

    C. Is Physical Touch Still a Taboo in Psychodynamic Psychotherapy? Howard E. Book, M.D.

    D. Professional Boundaries: Navigating Gray Areas and Avoiding Legal Trouble Linda M. Jorgenson, J.D.

S51. Women Psychiatrists Using Science to Heal

    A. Psychological Issues and Women Athletes: In a League of Their Own Altha J. Stewart, M.D.

    B. Catholic and Jewish Women Survivors of the Nazi Camps: Insights Leah J. Dickstein, M.D.

    C. Pursing Genetics Studies in Homogenous Portuguese Populations Michelle T. Pato, M.D.

    D. Outreach to the Indigent Mentally Ill in Rural India Geetha Jayaram, M.D.

    E. Innovative Models for Mental Health Services to Women in Hawaii Leslie H. Gise, M.D.

    F. From Bench to Bedside: Neurosteroids and Gender Differences in Psychiatry Christine E. Marx, M.D.

    G. HIV and Mental Illness Education Initiative in Sub-Saharan Africa Mary Kay Smith, M.D.

S52. Darwinian Evolution and Psychopathology

    A. Evolutionary Epidemiology and the Neuropsychiatry of Mania and Depression Daniel R. Wilson, M.D.

    B. Evolutionary Developmental Psychopathology Ian Pitchford, Ph.D.

    C. Clinical Equivalents in Phenotypic Expression: Implications for Research and Care Susan L. McElroy, M.D.

    D. Evolutionary Psychiatry: The End of the Beginning Hagop S. Akiskal, M.D.

S53. Comorbid Conditions in Schizophrenia: New Treatment Target or New Illness Model?

    A. Clinical Correlates and Chronology of Anxiety Comorbidity in Psychotic Disorders Giovanni B. Cassano, M.D.

    B. Comorbid Schizophrenia Syndromes: New Therapy Target or New Illness Model? Samuel G. Siris, M.D.

    C. Assessment and Characterization of Social Anxiety in Schizophrenia Stefano Pallanti, M.D.

    D. Impulsivity and Aggression in Schizophrenia: New Treatment Target Eric Hollander, M.D.

S54. ADHD: Longer-Term Treatment for a Chronic Disorder

    A. ADHD Treatment With a Once-Daily Formulation of Methylphenidate: A Two-Year Study Timothy E. Wilens, M.D.

    B. Preliminary Results of a Six-Month Trial of Methylphenidate in Adults With ADHD Thomas J. Spencer, M.D.

    C. Longer-Term Effectiveness of Various Treatments for ADHD: Results From the Multimodal Treatment Study of ADHD Laurence L. Greenhill, M.D.

    D. A 10-Year Follow-Up of ADHD Subjects Joseph Biederman, M.D.

    E. Does the Treatment of ADHD With Stimulant Medication Contribute to Illicit Drug Use and Abuse in Adulthood? Results From a 15-Year Prospective Study Russell A. Barkley, Ph.D.

S55. How to Launch a Successful Private Practice, (Part 3)

    A. Personal Factors Leading to a Successful Private Practice William E. Callahan Jr., M.D.

    B. Office Location and Design for Efficiency and Success Keith W. Young, M.D.

    C. Streamlining Overhead and Managing Your Business in Private Practice Keith W. Young, M.D.

    D. Marketing Your Unique Private Practice William E. Callahan Jr., M.D.

S56. Ethical Issues in the U.S. and France: Vive La Difference

    A. From One Culture to Another Charles De Brito, M.D.

    B. Impact of Culture on Ethics Ezra E.H. Griffith, M.D.

    C. About Patients’ Information in France: Is Electronic Medical Record Part of the Solution? Denis H. Chino, M.D.

    D. Patients Reading Their Own Records: Survey of the U.S. and Comment Thomas G. Gutheil, M.D.

    E. Psychiatric Treatment for Women of Child-Bearing Age: Ethical Aspects Christine Germain, M.D.

    F. What Is a Psychiatrist Doing Here? Kathleen M. Mogul, M.D.

S57. Psychiatrists With Psychiatric Disorders: The Fear of Stigma

    A. Psychiatric Residents in Manhattan: A Survey of Personal Psychiatric Treatment Sylvia P. Emmerich, M.D.

    B. Stigma Against the Mentally Ill and Its Effects on Treatment Paul J. Fink, M.D.

    C. The Role of the Training Director in Resident Mental Health: Strategies for Encouraging Treatment and Reducing Stigma Elizabeth Auchincloss, M.D.

    D. A Psychiatrist’s Personal Encounter With Stigma Francine Cournos, M.D.

S58. Addictions: Cutting-Edge Treatments

    A. Treatment of Cocaine Dependence Adam M. Bisaga, M.D.

    B. Treatments for Heroin Dependence Herbert D. Kleber, M.D.

    C. Office-Based Treatment of Opioid Addiction Laura F. McNicholas, M.D.

    D. Update on Marijuana and Club Drugs: Current and Potential Treatments David M. McDowell, M.D.

    E. Treatment of Comorbid Conditions Frances R. Levin, M.D.

S59. Internet: Technical, Clinical, and Societal American Association for Social Psychiatry and American Association for Technology in Psychiatry

    A. Addictions and the Internet Richard N. Rosenthal, M.D.

    B. Sex and the Internet Zebulon C. Taintor, M.D.

    C. Pseudocommunities on the Internet Steven E. Hyler, M.D.

    D. Internet Support: Self-Help Groups Robert C. Hsiung, M.D.

    E. Eating Disorders Meet the Internet: What Patients and Clinicians Encounter Joel Yager, M.D.

2 p.m.-5:30 p.m.

Review of Psychiatry (Part 2): Molecular Neurobiology for the Clinician Chairperson: Dennis S. Charney, M.D.

3 p.m.-5 p.m.

New Research Poster Session 7

7 p.m.-10 p.m.

Industry-Supported Symposia

IS35. Facing Unmet Needs: Atypical Antipsychotics for Mood and Anxiety Supported by Janssen Pharmaceutica

    A. Mechanism of Action of Atypical Antipsychotics in Mood and Anxiety Disorders Pierre Blier, M.D.

    B. Use of Atypical Antipsychotics in Mood Disorders Charles B. Nemeroff, M.D.

    C. Treatment of Anxiety Disorders: Therapeutic Challenges of the Future Olga Brawman-Mintzer, M.D.

    D. Atypical Antipsychotics in PTSD: Rationale and Role Murray B. Stein, M.D.

    E. Working With the Patient as a Co-Therapist: Strategies to Enhance Treatment Adherence Michael W. Otto, Ph.D.

IS36. Bipolar Disorder Across the Life Cycle Supported by Abbott Laboratories

    A. Reproductive Health and Metabolic Correlates in Women Receiving Treatment for Bipolar Disorder Natalie L. Rasgon, M.D.

    B. Bipolar Disorders in Adulthood John M. Zajecka, M.D.

    C. Secondary Manias and Comorbid Conditions James C.Y. Chou, M.D.

    D. Combination Treatments: What to Use and When Joseph R. Calabrese, M.D.

    E. Management of Side Effects and Treating to Wellness Charles L. Bowden, M.D.

IS37. Slowing Disease Progression and the Long-Term Management of Dementia Supported by Novartis Pharmaceuticals Corporation

    A. Mechanisms of Disease Progression in Dementia Nigel Greig, Ph.D.

    B. Targeting Cholinergic Therapy to Slow Disease Progression Steven G. Potkin, M.D.

    C. Brain Imaging and CSF Cholinesterase Inhibition: Long-Term Data Agneta Nordberg, M.D.

    D. A Critical Review of the Long-Term Data With Cholinesterase Inhibitors P. Murali Doraiswamy, M.D.

IS38. Optimizing Treatment for Patients With Schizophrenia: Targeting Positive Patient Outcomes Supported by Pfizer Inc.

    A. The Science of Antipsychotics: Mechanistic Insight Daniel E. Casey, M.D.

    B. Management of Acute Psychosis From Emergency to Stabilization Daniel L. Zimbroff, M.D.

    C.Beyond Control of Acute Exacerbation: Enhancing Affective and Cognitive Outcomes Herbert Y. Meltzer, M.D.

    D. Factors in Antipsychotic Drug Selection: Tolerability Considerations Henry A. Nasrallah, M.D.

    E. Obesity, Diabetes, and Metabolic Syndrome: New Challenges in Antipsychotic Drug Therapy Enrique Caballero, M.D.

    F. Long-Term Treatment Goals: Enhancing Healthy Outcomes Carol A. Tamminga, M.D.

IS39. Biological and Psychological Advances in the Treatment of Schizophrenia: Revisiting and Updating Meyer’s Psychobiology for the 21st Century Supported by Bristol-Myers Squibb Company

    A. Psychological Mechanisms of Psychosis: Implications for Psychotherapeutic Intervention Douglas Turkington, M.B.

    B. Biologic Mechanisms of Psychosis: From Dopamine Excess to Dopamine Stabilization Bryan L. Roth, M.D.

    C. What Is an Adequate Treatment Response? Establishing Therapeutic Goals in Schizophrenia Peter J. Weiden, M.D.

    D. Long-Term Treatment of Schizophrenia: Moving From a Relapse-Prevention Model to a Recovery Model John M. Kane, M.D.

    E. Diagnostic Boundaries Between Bipolar Disorder and Schizophrenia: Implications for Pharmacological Intervention Stephen M. Strakowski, M.D.

IS40. Real-World Challenges in Depression and Anxiety Supported by GlaxoSmithKline

    A. Long-Term Consequences of Social Anxiety Disorder: Breaking the Cycle Karen D. Wagner, M.D.

    B. Depression and Anxiety in Medical Illness: The Brain-Body Interface Prakash S. Masand, M.D.

    C. Overcoming Stigma and Optimizing Outcome in Late-Life Depression Lori J. Birdsong, M.D.

    D. The Clinical Challenge of Depression in Bipolar Disorder David L. Dunner, M.D.

IS41. Women and Psychiatric Disorders: Does Gender Matter for Treatment? Supported by Wyeth Pharmaceuticals

    A. Hormones and the Brain Meir Steiner, M.D.

    B. Sex, Hormones, and Depression: The Impact of Sex Steroids on Mood Across the Reproductive Life Cycle Claudio N. Soares, M.D.

    C. Trauma and PTSD in Women Shamsah B. Sonawalla, M.D.

    D. Women and Alcohol Use Disorders Shelly F. Greenfield, M.D.

    E. Does Gender Matter to Treatment? Jerrold F. Rosenbaum, M.D.

Interactive Graphics

Video

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Related Articles
Articles